Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Cost of Revenue (2018 - 2025)

Health Catalyst (HCAT) has disclosed Cost of Revenue for 8 consecutive years, with $42.5 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Cost of Revenue rose 6.04% year-over-year to $42.5 million, compared with a TTM value of $137.1 million through Jun 2025, down 27.2%, and an annual FY2023 reading of $164.1 million, up 14.72% over the prior year.
  • Cost of Revenue was $42.5 million for Q2 2025 at Health Catalyst, down from $43.2 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $114.1 million in Q4 2023 and bottomed at $11.3 million in Q3 2024.
  • Average Cost of Revenue over 5 years is $36.1 million, with a median of $33.1 million recorded in 2021.
  • The sharpest move saw Cost of Revenue crashed 58.49% in 2023, then soared 144.31% in 2024.
  • Year by year, Cost of Revenue stood at $71.2 million in 2021, then dropped by 27.96% to $51.3 million in 2022, then soared by 122.4% to $114.1 million in 2023, then crashed by 90.06% to $11.3 million in 2024, then soared by 274.54% to $42.5 million in 2025.
  • Business Quant data shows Cost of Revenue for HCAT at $42.5 million in Q2 2025, $43.2 million in Q1 2025, and $11.3 million in Q3 2024.